omniscan 0,5 mmol/ml sol. inj. i.v. flac.
ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide
omniscan 0,5 mmol/ml sol. inj. i.v. flac.
ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide
omniscan 0,5 mmol/ml sol. inj. i.v. ser. préremplie
ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide
omniscan 0,5 mmol/ml sol. inj. i.v. ser. préremplie
ge healthcare bv-srl - gadodiamide 287 mg/ml - solution injectable - gadodiamide
gadobutrol injection
fresenius kabi usa, llc - gadobutrol (unii: 1bj477io2l) (gadolinium cation (3+) - unii:azv954tz9n) - gadobutrol injection is indicated for use with magnetic resonance imaging (mri) in adult and pediatric patients, including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. gadobutrol injection is indicated for use with mri in adult patients to assess the presence and extent of malignant breast disease. gadobutrol injection is indicated for use in magnetic resonance angiography (mra) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. gadobutrol injection is indicated for use in cardiac mri (cmri) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (cad). gadobutrol injection is contraindicated in patients with history of severe hypersensitivity reactions to gadobutrol injection. gbcas cross the placenta and result in fetal exposure and gadolinium retention.
omniscan 0,5 mmol/ml oldatos injekció
ge healthcare as - gadodiamide -
omniscan 0.5 mmol/ ml
ge healthcare as - gadodiamid - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.5 mmol/ ml
omniscan 0.5 mmol/ ml
ge healthcare as - gadodiamid - injeksjonsvæske, oppløsning - 0.5 mmol/ ml
omniscan 0,5 mmol/ml injektionsvätska, lösning
ge healthcare as - gadodiamid - injektionsvätska, lösning - 0,5 mmol/ml - gadodiamid 287 mg aktiv substans - gadodiamid
omniscan 0,5 mmol/ml injektionsvätska, lösning i förfylld spruta
ge healthcare as - gadodiamid - injektionsvätska, lösning i förfylld spruta - 0,5 mmol/ml - gadodiamid 287 mg aktiv substans - gadodiamid